2687-0940Challenges in modern medicine2687-094010.18413/2687-0940-2020-43-4-522-53851CARDIOLOGY<strong>Predictive value of the N-terminal prohormone of brain natriuretic peptide in the long-term prognosis of ventricular arrhythmia in diabetic patients with acute coronary syndrome of young and middle age</strong><strong>Predictive value of the N-terminal prohormone of brain natriuretic peptide in the long-term prognosis of ventricular arrhythmia in diabetic patients with acute coronary syndrome of young and middle age</strong>WangZhemingWangZhemingpolarbear8822@mail.ruAsafievaElena A.AsafievaElena A.Elennatolna@yandex.ruMakeevaTatiana I.MakeevaTatiana I.tatianamakeeva@gmail.com202043400

The article investigates the prognostic value of pro-B-type N-terminal natriuretic peptide (NT-proBNP) in connection with ventricular extrasystoles (VES) in a population of patients with diabetes mellitus with acute coronary syndrome (ACS) after successful coronary reperfusion by percutaneous coronary intervention (PCI). Patients with ACS were examined by defining biomarkers and performing echocardiography (EchoCG) on the first day of ACS after PCI with stenting of the infarction-related coronary artery, and Holter monitoring of electrocardiography (HM-ECG) on the second day after PCI; 12 months later, EchoCG, HM-ECG and NT-proBNP determination were repeated. It was found that the incidence of VES in the long-term prognosis among ACS patients with diabetes of young and middle age was more frequent than in patients without diabetes. A positive correlation was found between the NT-proBNP level and ventricular arrhythmia in ACS patients with diabetes mellitus. It has been proven that a high level of NT-proBNP on the first day in patients with ACS after PCI as an independent indicator of risk to development of VES in long-term prognosis.

The article investigates the prognostic value of pro-B-type N-terminal natriuretic peptide (NT-proBNP) in connection with ventricular extrasystoles (VES) in a population of patients with diabetes mellitus with acute coronary syndrome (ACS) after successful coronary reperfusion by percutaneous coronary intervention (PCI). Patients with ACS were examined by defining biomarkers and performing echocardiography (EchoCG) on the first day of ACS after PCI with stenting of the infarction-related coronary artery, and Holter monitoring of electrocardiography (HM-ECG) on the second day after PCI; 12 months later, EchoCG, HM-ECG and NT-proBNP determination were repeated. It was found that the incidence of VES in the long-term prognosis among ACS patients with diabetes of young and middle age was more frequent than in patients without diabetes. A positive correlation was found between the NT-proBNP level and ventricular arrhythmia in ACS patients with diabetes mellitus. It has been proven that a high level of NT-proBNP on the first day in patients with ACS after PCI as an independent indicator of risk to development of VES in long-term prognosis.

acute myocardial infarctiondiabetes mellituscoronary angiographyN-terminal prohormonebrain natriuretic peptideventricular arrhythmiaventricular extrasystolesacute myocardial infarctiondiabetes mellituscoronary angiographyN-terminal prohormonebrain natriuretic peptideventricular arrhythmiaventricular extrasystolesСписок литературыAbdullaev R.F., Melikov A.A., Guseynzade R.R., Garamamedli S.Ya. 2014. Kazan&#39;: 41. Otsenka svyazi urovnya mozgovogo natriyureticheskogo peptida pri stabil&#39;noy stenokardii s zheludochkovymi aritmiyami i ishemiey miokarda [Assessment of the relationship between the level of brain natriuretic peptide in stable angina pectoris with ventricular arrhythmias and myocardial ischemia]. V kn: Rossiyskogo natsional&#39;nogo kongressa kardiologov. (in Russian).Ahmedova Je.B., Mardanov B.U., Mamedov M.N. 2015. Opredelenie narusheni &nbsp;vegetativnoj nervnoj sistemy v kardiologicheskoj praktike: fokus na analiz variabel&#39;nosti serdechnogo ritma [Disorders of the autonomic nervous system in the cardiology practice: focus on the analysis of heart rate variability]. Racional&#39;naja farmakoterapija v kardiologii. 11 (4): 426&ndash;430 (in Russian).Bineeva M.N. 2019. Perinatal&#39;naja gipoksija i diastolicheskaja funkcija miokarda novorozhdennyh [Perinatal hypoxia and diastolic function of the myocardium of newborns]. Rossijskij kardiologicheskij zhurnal. 24 (S2): 23&ndash;24 (in Russian).Girivenko A.I., Nizov A.A. 2013. Variabel&#39;nost&#39; ritma serdca u bol&#39;nyh s ostrym koronarnym sindromom v zavisimosti ot provodimoj terapii [Heart rate variability in patients with acute coronary syndromes according to treatment]. Sibirskij medicinskij zhurnal (Irkutsk). 123 (8): 74&ndash;77 (in Russian).Dedov I.I., Shestakova M.V., Vikulova O.K. 2015. Gosudarstvennyj registr saharnogo diabeta v Rossijskoj Federacii: status 2014 g. i perspektivy razvitija [Heart rate variability in patients with acute coronary syndromes according to treatment]. Saharnyj diabet. 18 (3): 5&ndash;23 (in Russian).Denisova A.G., Tatarchenko I.P., Pozdnjakova N.V. 2016. Strukturno-funkcional&#39;noe remodelirovanie serdca pri saharnom diabete: kliniko-instrumental&#39;naja ocenka [Structural and functional heart remodeling in diabetes mellitus: clinical and instrumental evaluation]. Jendokrinologija: novosti, mnenija, obuchenie. 3 (16): 94&ndash;99 (in Russian).Dushina A.G. Libis R.A. 2017. Pozdnie potencialy zheludochkov u pacientov s hronicheskoj serdechnoj nedostatochnost&#39;ju s sohranennoj frakciej vybrosa. [Late ventricular potentials in chronic heart failure patients with preserved ejection fraction]. Al&#39;manah klinicheskoj mediciny. 45 (3): 247&ndash;253 (in Russian).Elsukova O.S., Nikitina E.A., Zhuravleva O.L. 2015. Vozmozhnosti diagnostiki kardial&#39;noj nejropatii u bol&#39;nyh s saharnym diabetom 2 tipa i komorbidno patologiej [Facilities of cardial neuropathy diagnostics in patients suffering from diabetes mellitus type 2 and comorbid pathology]. Sibirskij medicinskij zhurnal (Irkutsk). 133 (2):67&ndash;72 (in Russian).Ibatov A.D. 2019. Pokazateli variabel&#39;nost&#39; ritma serdtsa u bol&#39;nykh ishemicheskoy bolezn&#39;yu serdtsa s khronicheskoy serdechnoy nedostatochnost&#39;yu i metabolicheskim sindromom [Indicators of heart rate variability in patients with ischemic heart disease with chronic heart failure and metabolic syndrome]. In: Rossiyskiy kardiologicheskiy zhurnal. Ekaterinburg: 24&ndash;25 (in Russian).Logacheva I.V., Baranceva N.G. 2013. Dinamika osnovnyh parametrov holterovskogo monitorirovanija jelektrokardiogrammy u bol&#39;nyh infarktom miokarda s zheludochkovymi narushenijami ritma serdca [Change of the main parameters of 24-hour ekg monitoring in patients with myocardial infarction associated with ventricular arrhythmias]. Kazanskij medicinskij zhurnal. 94 (2): 176&ndash;180 (in Russian).Nikitina E.A., Chicherina E.N., Elsukova O.S. 2016. Osobennosti variabel&#39;nosti serdechnogo ritma i cirkadnogo indeksa u pacientov s ostrym koronarnym sindromom s pod&quot;emom segmenta ST i saharnym diabetom 2 tipa na fone komorbidno patologii [Heart rate variability and circadian index in patients with st segment elevation acute coronary syndrome, type 2 diabetes mellitus and comorbid pathology]. Sibirskij medicinskij zhurnal (Irkutsk). 145 (6):16&ndash;19 (in Russian).Sabitova O.V., Kakorin S.V. 2012. Narusheniya ritma i provodimosti u bol&#39;nykh s postinfarktnym kardiosklerozom i sakharnym diabetom 2 tipa [Rhythm and conduction disorders in patients with postinfarction cardiosclerosis and type 2 diabetes mellitus]. V kn: Sbornik materialov V Vserossiyskogo foruma &laquo;Voprosy neotlozhnoy kardiologii &ndash; 2012&raquo;. M.: 17 (in Russian).Tatarchenko I.P., Pozdnjakova N.V., Denisova A.G., Morozova O.I. 2015. Kliniko-instrumental&#39;nyj analiz zheludochkovyh narushenij ritma pri diastolicheskoj serdechnoj nedostatochnosti u bol&#39;nyh saharnym diabetom 2-go tipa [. The clinical and instrumental analysis of ventricular rhythm disturbances in the patients with type 2 diabetes mellitus suffering from diastolic cardiac insufficiency]. Problemy Jendokrinologii. 61 (2): 21&ndash;27 (in Russian).Caglar Ozmen, Ali Deniz, Onur S. Deveci, Caglar E. Cagliyan, Aziz İ. Celik, İbrahim Yildiz, Pinar &Ouml;. Yildiz, Mesut Demir, Mehmet Kanadasi. 2017. Association among tenascin-C and NT-proBNP levels and arrhythmia prevalence in heart failure. Clin. Invest. Med. 40: E219 &ndash; E227.Julia Brox Skranes, Gunnar Einvik, Silje Kjeka Namtvedt, Anna Randby, Harald Hrubos-Str&oslash;m, Jon Brynildsen, Tor-Arne Hagve, Virend K. Somers, Helge R&oslash;sj&oslash;, Torbj&oslash;rn Omland. 2016. Biomarkers of cardiovascular injury and stress are associated with increased frequency of ventricular ectopy: a population-based study. BMC Cardiovasc. Disord. 16 (1): 233.Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., Lancellotti P., Muraru D., Picard M.H., Rietzschel E.R., Rudski L., Spencer K.T., Tsang W., Voigt J.U. 2015. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart. J. Cardiovasc. Imaging. 16 (3): 233&ndash;70.Maier B., Thimme W., Kallischnigg G., Graf-Bothe C., R&ouml;hnisch J.U., Hegenbarth C., Theres H. 2006. Berlin Myocardial Infarction Registry. Does Diabetes Mellitus Explain the Higher Hospital Mortality of Women with Acute Myocardial Infarction? Results from the Berlin Myocardial Infarction Registry. J. Investig. Med. 54 (3): 143&ndash;151.Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., Dai S., Ford E.S., Fox C.S., Franco S., et al., Fullerton H.J., Gillespie С., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Judd S.E., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Mackey R.H., Magid D.J., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R. 3rd, Moy C.S., Mussolino M.E., Neumar R.W., Nichol G., Pandey D.K., Paynter N.P., Reeves M.J., Sorlie P.D., Stein J., Towfighi A., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. 2014. Executive summary: heart disease and stroke statistics &ndash; 2014 update: a report from the American Heart Association. Circulation. 129 (3): 399&ndash;410.Omland T. 2008. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Crit. Care. Med. 36 (1 Suppl): S17&ndash;27.Sima A.A., Thomas P.K., Ishii D., Vinik A. 1997. Diabetic neuropathies. Diabetologia. 40 Suppl 3: B 74&ndash;77.Torbj&oslash;rn Omland, James A. de Lemos, David A. Morrow, Elliot M. Antman, Christopher P. Cannon, Christian Hall, Eugene Braunwald. 2002. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Аm. J. Cardiol. 89 (4): 463&ndash;5.